Brief: Pulmatrix Announces $40 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Feb 11 (Reuters) - Pulmatrix Inc PULM.O :
* PULMATRIX ANNOUNCES $40 MILLION REGISTERED DIRECT OFFERING
PRICED AT-THE-MARKET UNDER NASDAQ RULES
* PULMATRIX - ENTERED DEFINITIVE AGREEMENTS WITH
HEALTHCARE-FOCUSED INSTITUTIONAL INVESTORS FOR PURCHASE, SALE OF
20 MILLION COMMON SHARES AT $2PER SHARE
Source text for Eikon: ID:nPn8d96wsa
Further company coverage: PULM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulmatrix
See all newsBrief: Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger
Pulmatrix Q2 loss narrows on clinical development hold
Pulmatrix Q1 net loss narrows, clinical development on hold
Brief: Pulmatrix Announces Closing Of Preferred Stock Transaction As Part Of Planned Merger
NASDAQ RESUMED AT 09:00 AM